Hepatology News

PHILADELPHIA — Patients with cirrhosis had an increased risk for bleeding within 30 days of colorectal endoscopic mucosal resection compared with controls, although the need for reintervention or ICU admission was similar between groups.

The relationship between health care providers and referral sources can present complex legal challenges.

PHILADELPHIA — Rifaximin monotherapy reduced episode recurrence and “may confer” a survival benefit compared with lactulose monotherapy among patients with cirrhosis and a history of overt hepatic encephalopathy, according to a presenter.

PHILADELPHIA — Primary sclerosing cholangitis is an independent risk factor for colorectal cancer, with an “almost three-times higher” risk among patients without inflammatory bowel disease vs. the general population, a researcher reported.

A diagnostic tool based on speech variables helped identify minimal hepatic encephalopathy and may predict time to development of overt hepatic encephalopathy in patients with cirrhosis, according to a study published in Hepatology.

Survival for people with hepatocellular carcinoma has improved over the last decade, according to study results.

Nonqualified plans offer a valuable alternative or supplement to qualified retirement plans for physicians seeking to enhance their retirement savings.

Rates of liver-related mortality increased by 19.1% from 2018 to 2021 and varied “several-fold” between states, underscoring the need for improved access to liver transplantation regardless of location, according to researchers.

Necessary changes within the health care system will only arise when workers are allowed more time and space personally and professionally, with ChatGPT the method by which this transformation can occur, according to Robert Pearl, MD.

Patients who tested positive for hepatitis D virus antibodies were at greater risk for developing hepatocellular carcinoma and other adverse liver-related outcomes, often at a young age, according to study results.